Lipid degradation promotes prostate cancer cell survival

Author:

Itkonen Harri M.1,Brown Michael2,Urbanucci Alfonso13,Tredwell Gregory4,Ho Lau Chung4,Barfeld Stefan1,Hart Claire2,Guldvik Ingrid J.1,Takhar Mandeep5,Heemers Hannelore V.678,Erho Nicholas5,Bloch Katarzyna9,Davicioni Elai5,Derua Rita10,Waelkens Etienne10,Mohler James L.11,Clarke Noel21213,Swinnen Johan V.9,Keun Hector C.4,Rekvig Ole P.14,Mills Ian G.1315

Affiliation:

1. Prostate Cancer Research Group, Centre for Molecular Medicine Norway, University of Oslo, Oslo, Norway

2. Genito Urinary Cancer Research Group, Institute of Cancer Sciences, University of Manchester, Manchester, United Kingdom

3. Department of Molecular Oncology, Institute for Cancer Research and Oslo University Hospital, Oslo, Norway

4. Department of Surgery and Cancer, Imperial College London, London, United Kingdom

5. GenomeDx Biosciences, Vancouver, British Columbia, Canada

6. Department of Cancer Biology, Cleveland Clinic, Cleveland, Ohio, USA

7. Department of Urology, Cleveland Clinic, Cleveland, Ohio, USA

8. Department of Hematology/Medical Oncology, Cleveland Clinic, Cleveland, Ohio, USA

9. Department of Oncology, Laboratory of Lipid Metabolism and Cancer, LKI Leuven Cancer Institute, KU Leuven-University of Leuven, Leuven, Belgium

10. Department of Cellular and Molecular Medicine, Laboratory of Protein Phosphorylation and Proteomics, KU Leuven-University of Leuven, Leuven, Belgium

11. Department of Urology, Roswell Park Cancer Institute, Buffalo, New York, USA

12. PCUK/Movember Centre of Excellence for Prostate Cancer Research, CRUK Manchester Institute for Cancer Research, University of Manchester, Manchester, UK

13. Department of Urology, The Christie NHS Foundation Trust, Manchester, UK

14. Department of Medical Biology, University of Tromso, Tromso, Norway

15. PCUK/Movember Centre of Excellence for Prostate Cancer Research, Centre for Cancer Research and Cell Biology (CCRCB), Queen's University Belfast, Belfast, UK

Publisher

Impact Journals, LLC

Subject

Oncology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3